Previous studies have suggested inhibition of fatty acid oxidation or YAP may merit exploration as a potential therapeutic strategy for mitigating PA‐ driven tumor metastasis.[39, 95] In addition, targeting the FA receptor CD36 with CD36‐blocking antibodies therapeutically inhibited metastasis of OSCC tumors.[50] Therefore, these studies and our current data advance the identification of potential targets for suppressing PA‐mediated metastasis. Here, CD36 is linked to neoplasm.